Mitochondrial sites of reactive oxygen species generation in cells.
Mitochondrial sites of reactive oxygen species generation in cells.
批准号:
7626648
负责人:
Martin D Brand
金额:
$48.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2011-07-31
关键词:
AddressAgeAgingAstrocytesBiological AssayBiological ModelsCell RespirationCellsComplexConfusionConsensusDiseaseElectron TransportElectron Transport Complex IIIElectronsFailureFibroblastsFigs - dietaryFlavinsFoundationsFree RadicalsGenerationsGlycerolGoalsHealth BenefitHumanKnowledgeMeasurementMeasuresMethodsMitochondriaMuscle CellsMyoblastsNeuronsOxidative StressOxidoreductasePancreasPatternPhasePhysiologicalProductionPublic HealthQuinonesReactive Oxygen SpeciesRelative (related person)ReporterResearchRisk FactorsRoleRotenoneSignal TransductionSiteSolidSynaptosomesTestingTissuesVertebratesage relatedbaseburden of illnesscell injurydesignelectron-transferring-flavoprotein dehydrogenasefatty acid oxidationinhibitor/antagonistinnovationinorganic phosphateinsulinomalung Carcinomanovel strategiesoxidationpublic health relevancepyruvate dehydrogenaserepairedsenescencetheoriestransport inhibitor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The dominant theory of aging is the mitochondrial free radical theory, which proposes that the production of reactive oxygen species (ROS) by intracellular mitochondria is the primary cause of cellular damage and aging. However, the theory is at best incomplete. To test it critically and to manipulate radical production to promote healthspan, it is therefore crucial to fully understand the mechanisms and specific sites of mitochondrial radical generation to assess its role in age-related diseases and aging, ultimately to allow rational design of beneficial therapies. Despite much research, such understanding is currently lacking. This study will address this deficit by measuring the rate of cellular mitochondrial ROS generation at each specific site in the electron transport chain in cells relevant to aging, particularly neurons, muscle cells and fibroblasts. Previous attempts to identify the sites involved have led to confusion because of a conceptual problem: to define the sites, electron transport inhibitors are added, but they inevitably distort electron distribution in the chain and the pattern of ROS production. This problem will be circumvented by a key innovation: using inhibitors to define sites in a first phase in which endogenous reporter signals are calibrated in terms of ROS production from each site, but omitting them in the measuring phase when the endogenous reporter signals are used to calculate ROS generation from each site under a single experimental condition when several sites may operate simultaneously. The hypothesis to be tested is that at least one site in the mitochondrial electron transport chain produces significant ROS in cells and is the main oxidative stress generator. In the mitochondrial free radical theory, ROS generation at this site would be the primary cause of aging and its diseases. The hypothesis will be investigated by a rigorous stepwise approach: first assay rates from each site in a model system (isolated mitochondria), then build on this platform to assay the sites of ROS production in cells. Studies will have the following specific aims. (1) Establish and validate measurements of ROS production from different sites in the electron transport chain of isolated mitochondria in the absence of electron transport inhibitors. (2) Using these methods, determine the relative rate of ROS production by each site in isolated mitochondria from different ageing-relevant tissues, oxidizing different substrates in different states, at different ages. (3) Transfer the methods to cells and establish the relative rate of ROS production by each mitochondrial site and the quantitative importance of mitochondrial ROS production. We will use synaptosomes and experimentally-amenable cells (including neurons, astrocytes, normal and senescent fibroblasts, C2C12 myoblasts, and pancreatic insulinoma cells oxidizing physiological substrates in different states. PUBLIC HEALTH RELEVANCE: Since age is the primary risk factor for many diseases, understanding the mechanisms of aging may allow us to significantly reduce the burden of disease and increase human healthspan - even a small decrease in age-related cellular damage may have widespread public health benefits. Free radicals generated during normal oxidative metabolism damage cells and may cause aging. This project will use an innovative stepwise approach to identify measure and compare the specific cellular sites at which these radicals are produced, opening the way for rational strategies to lower radical production and decrease the diseases of aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leica TCS SP5 MP confocal and two-photon microscope
-
批准号:8247639
-
项目类别:
-
资助金额:$59.91万
-
财政年份:2012
-
负责人:Martin D Brand
-
依托单位:
Mitochondrial sites of reactive oxygen species generation in cells.
-
批准号:7896575
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2009
-
负责人:Martin D Brand
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: